Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gary K. Schwartz
Selinexor (KPT-330) Induces Tumor Suppression Through Nuclear Sequestration of IκB and Downregulation of Survivin
Clinical Cancer Research
Cancer Research
Oncology
Extrarenal Perivascular Epithelioid Cell Tumors (PEComas) Respond to mTOR Inhibition: Clinical and Molecular Correlates
International Journal of Cancer
Cancer Research
Oncology
Preclinical and First-In-Human Phase I Studies of KW-2450, an Oral Tyrosine Kinase Inhibitor With Insulin-Like Growth Factor Receptor-1/Insulin Receptor Selectivity
Cancer Science
Cancer Research
Medicine
Oncology
BRD4-targeted Therapy Induces Myc-Independent Cytotoxicity in Gnaq/11-Mutatant Uveal Melanoma Cells
Oncotarget
Oncology
MLN-8237: A Dual Inhibitor of Aurora a and B in Soft Tissue Sarcomas
Oncotarget
Oncology
A Phase I Clinical Trial of FOLFIRI in Combination With the Pan-Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma
Cancer Research
Cancer Research
Oncology
Evidence for Involvement of Mitogen-Activated Protein Kinase, Rather Than Stress-Activated Protein Kinase, in Potentiation of 1-Β-D-Arabinofuranosylcytosine-Induced Apoptosis by Interruption of Protein Kinase C Signaling
Molecular Pharmacology
Molecular Medicine
Pharmacology
Ifosfamide May Be Safely Used in Patients With End Stage Renal Disease on Hemodialysis
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
